Feed ACT.DE
AC
AlzChem Group AG
ACT.DE · XETRA
157.60 € -0.19% (-0.30 €)
1M -8.07%
Market Cap 1.6B €
P/E Ratio 25.14x
Div. Yield 1.33%
ROE 24.45%
Bulios Fair Price
144.86 €
8.1% downside
Current Price
157.6 €
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ACT.DE is currently overvalued relative to its market price. How does it work?
Valuation
29 /100
Expensive P/E 25.14x
EV/EBITDA 14.34x
P/S 2.84x
Growth
73 /100
Growing EPS growth 28.35%
Rev. growth 1.21%
Book val. growth 21.18%
Profitability
84 /100
Strong Gross margin 31.59%
Net margin 11.29%
Op. margin 14.73%
Quality
93 /100
Excellent ROIC 11.81%
ROE 24.45%
ROA 10.27%
Debt
100 /100
Low Debt/Equity 0.18x
Current ratio 2.49x
Int. coverage 47.72x
Stability
79 /100
Stable Beta 0.55x
Rev. volatility 1.41%
EPS volatility 23.06%
Ask StockBot about ACT.DE
Online
Sector
Basic Materials
Industry
Chemicals - Specialty
CEO
Andreas Niedermaier
Employees
1,680
Headquarters
Trostberg
Upcoming events
29 OCT
Earnings
Upcoming earnings report